സെപ്റ്റംബർ പാദത്തിലെ മികച്ച പ്രവർത്തനഫലങ്ങളെത്തുടർന്ന് സനോഫി കൺസ്യൂമർ ഹെൽത്ത്കെയർ ഓഹരികൾ 11 ശതമാനം ഉയർന്നു. കമ്പനിയുടെ ലാഭം 22.2 ശതമാനം വർധിച്ച് 77 കോടി രൂപയായി. വരുമാനത്തിലും വിപണി വിഹിതത്തിലും വലിയ വളർച്ചയാണ് രേഖപ്പെടുത്തിയത്. ഉൽപ്പന്നങ്ങളുടെ മികച്ച പ്രകടനവും വിതരണ ശൃംഖലയിലെ വിപുലീകരണവുമാണ് ഈ നേട്ടത്തിന് പിന്നിലെന്ന് മാനേജിംഗ് ഡയറക്ടർ ഹിമാൻഷു ബക്ഷി വ്യക്
Sanofi Consumer Healthcare share price surged as much as 11% in Thursday's trading session after the company reported strong set of numbers during the September quarter FY27.
Sanofi Consumer shares opened at ₹3,502.20 on NSE today, as compared to previous close of ₹3,322.80 on Wednesday and touched an intraday high of ₹3,771.90 on 29 October.
Sanofi Consumer Q3 results 2026
Sanofi Consumer Healthcare India reported a 22.2% year-on-year rise in consolidated profit to ₹77 crore in the September quarter of calendar year 2026, compared with ₹63 crore in the corresponding period last year.
Revenue from operations increased 12.4% year-on-year to ₹263 crore from ₹234 crore. EBITDA rose to ₹102 crore from ₹85 crore, while the EBITDA margin improved to 38.7% from 36.4%. Meanwhile, total expenses climbed to ₹164.8 crore from ₹152.8 crore in the year-ago quarter.
The company reported 19% year-on-year growth in domestic sales. For the nine months ended September 2026, revenue from operations grew 16% to ₹728 crore from ₹627.4 crore in the corresponding period last year. Domestic sales increased 15%, supported by product relaunches, while exports recorded 19% growth.
Commenting on the performance, Himanshu Bakshi, managing director of Sanofi Consumer Healthcare India, said the September-quarter results reflected the effective execution of the company's strategy and the strength of its product portfolio.
He added that growth was supported by higher volumes and market share gains across key brands. Continued investments in brand building, expanding distribution networks and engaging with healthcare professionals were also helping the company strengthen its reach among consumers.
Sanofi Consumer share price performance
Sanofi share price has gained 5.40% over the past week, indicating a recent recovery after sustained selling pressure. However, the stock has declined 11.07% over the past month and 24.60% year-to-date.
On a one-year basis, Sanofi shares have fallen 26.38%, reflecting significant weakness in its overall performance despite the recent weekly gains.
More to come..